Mathias Uhlen

Active Investor

Professor at KTH Royal Institute of Technology

Stockholm County

Mathias Uhlen, Professor at KTH Royal Institute of Technology is an active investor based in Stockholm County. This profile covers what Mathias Uhlen backs, at which stage, and how founders can reach out in 2026.

Dr. Mathias Uhlén serves as Co-Founder & Board Member at Atlas Antibodies. Dr. Uhlén is a Co-Founder and serves as the President and Chairman at ScandiEdge Therapeutics. He served as a Senior Advisor at HealthCap. He served as a Board Member at Novonesis (Novozymes). He served as a Board Member at Alligator Bioscience. He is a Co-Founder and serves as a Board Member at Atlas Antibodies. He is a Professor in biotechnology at KTH Royal School of Technology and Guest Professor at the Karolinska Institute. He is the Program Director of the Human Protein Atlas (HPA) project, which is financed by the Knut and Alice Wallenberg Foundation. Mathias is Chairman of the Board of ScandiBio Therapeutics AB, ScandiEdge Therapeutics AB, MU Bioteknik AB, Antibodypedia AB, Atlas Intressenter AB, A05 Diagnostics AB, and ProteomEdge AB. He holds a Ph.D. in Biotechnology from KTH Royal Institute of Technology.

Investor type: Angel
Stages: Early Stage VenturePre SeedLate Stage Venture
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaSaaS & EnterpriseClimate & EnergyQuantum & SemiconductorsManufacturing & IndustrialEdTech
Location: Stockholm County
Typical check: $500K
Past investments: 4

Notable investments

Alligator BioscienceMindforce Game LabSciLifeLabsCapitainer

How to reach Mathias Uhlen

Angels and operators like Mathias Uhlen reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Mathias Uhlen invest in?

Mathias Uhlen invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and SaaS & Enterprise, typically at Early Stage Venture, Pre Seed and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.